Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154087 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers
A Phase 2 study, sponsored by Healthpoint.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT02154087: Clinical Trial Phase 2 study, sponsored by Healthpoint.
NCT02154087 is a Phase 2 study that was terminated before completion, run by Healthpoint. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154087, a Phase 2 study, was terminated before completion, sponsored by Healthpoint.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Assess the influence of HP802-247 on biochemical and cellular markers of inflammation in chronic venous leg ulcers
Primary Outcome
The following mediators were to be measured for the chronic ulcer stage: IL-1β, IL-6, TNF-α, IFN, MMP-2, and MMP-9, and the following for the resolving ulcer stage: PGE-2, Lipoxin, GM-CSF, TGFβ, IL-10, LL-37, Indoleamine 2,3-Dioxygenase (IDO), and Arginase (ARG-1). Each of the soluble mediators were to be plotted versus measurement time point \[i.e., (pre-study run-in visit (RV)1), baseline (RV3), study visit (SV)2, and SV3\]) and by subjects' quartile of percent reduction (%) in target wound ar
Interventions
- BIOLOGICAL HP802-247
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Why NCT02154087 stopped before completion
NCT02154087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which HP802-247 is the first listed.
NCT02154087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154087 about?
NCT02154087 is a clinical study titled "A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers". Assess the influence of HP802-247 on biochemical and cellular markers of inflammation in chronic venous leg ulcers
What is the current status of trial NCT02154087?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2014-07. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02154087?
The interventions under investigation include: HP802-247 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02154087?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02154087's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia